Delivery Order SPE2DB20D2014-SPE2DB25FD14C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Januvia 50 mg tablets (90-count packages) at a ceiling value of $1,925.58. This competitively awarded, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of September 12, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Januvia 50 mg tablets (90-count) valued at $1,316.00. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and was awarded on a competitive, non-set-aside basis. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,182.92 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Januvia 50 mg tablets (90-count units). The contract, which represents a non-set-aside competitive award, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,328.79 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and carries an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $2,654.77 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Januvia 50 mg tablets (90-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by September 15, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child order under AmerisourceBergen's larger federal contract portfolio....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed-price contract valued at $3,638.20. The delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-competitive, direct fulfillment against AmerisourceBergen's existing indefinite delivery contract. Performance will be executed from the company's corporate headquarters location...
- The Defense Logistics Agency awarded a $4,178.82 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 10, 2025, and performance to be executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $2,182.92 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Januvia 50 mg tablets in a 90-count package. This competitive award, valued at $2,910.56, represents a firm fixed-price delivery order with an ultimate completion date of September 24, 2025. The contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FD14CDelivery Order
The Defense Logistics Agency awarded a $4,365.84 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Januvia 50 mg tablets (90-count). This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing with a completion date of September 29, 2025. The contract is to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a wide range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a primary vendor through the DLA's Pharmaceutical Prime Vendor program, AmerisourceBergen maintains the infrastructure and distribution networks necessary to support military healthcare needs globally, with this particular delivery order supplying diabetes medication to support military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 9/26/25 |